Fifth Third Bancorp’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.26K Buy
+295
New +$2.89K ﹤0.01% 4078
2023
Q2
– Sell
-500
Closed -$2.64K – 2720
2023
Q1
$2.64K Buy
+500
New +$2.37K ﹤0.01% 2507

Other funds holding OCUL

Fifth Third Bancorp's OCUL Position: Q3 2026 in Review

Fifth Third Bancorp opened a new position in Ocular Therapeutix (OCUL) in Q3 2026: 295 shares worth $2.26K. The stake represents ﹤0.01% of the portfolio and ranks #4078 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in OCUL as recently as Q1 2023.

Fifth Third Bancorp first reported a position in OCUL in Q1 2023 and has held it in 2 quarters since. The position peaked at $2.64K in Q1 2023. 263 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.

  • Fifth Third Bancorp held 295 shares of Ocular Therapeutix worth $2.26K as of Q3 2026.
  • Ocular Therapeutix was a new Fifth Third Bancorp position in Q3 2026.
  • Ocular Therapeutix made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q3 2026, its #4078 holding.
  • Fifth Third Bancorp first reported a position in Ocular Therapeutix in Q1 2023 and has held it in 2 quarters since.
  • Fifth Third Bancorp's Ocular Therapeutix position peaked at $2.64K in Q1 2023.
  • 263 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.

Based on Fifth Third Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.